Description: A biodegradable implant that can achieve 18 months duration using etonogestrel /cholesterol fused pellets.
Delivery Method: Subdermal
Duration Type: Long-acting
Duration: 18 months
Active Pharmaceutical Ingredient (API):
Inactive material: cholesterol
Multipurpose Preventive Technology (MPT): No
Project Phase: Pre-Clinical and Clinical Development
Development Stage: Pre-clinical
Began discovery in: 2015
Active Development: Yes
- Builds upon earlier work on NET Pellets with Anterion Therapeutics.